ArticleJournal of translational medicine2013

Metallothionein 2A inhibits NF-κB pathway activation and predicts clinical outcome segregated with TNM stage in gastric cancer patients following radical resection.

Yuanming Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.